Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Eusebio

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Parkinson'S Disease|June 27, 2025
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's diseaseMathilde Boussac, Florent Faggianelli, Estelle Harroch, et al.
Journal of Parkinson'S Disease|December 13, 2021
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II)Mathilde Boussac, Christophe Arbus, Helene Klinger, et al.
Clinical Parkinsonism & Related Disorders|February 20, 2026
Effects of deep brain stimulation on non motor fluctuations in Parkinson's disease (assessed with the NMF severity scale)Christian Matta, Camille Comet, Corentin Gaillard, et al.
BMJ Neurology Open|January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysisAymeric Lanore, Marion Houot, Aymeric Basset, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2020
Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective StudyMarie des Neiges Santin, Paul Voulleminot, Agathe Vrillon, et al.
The Lancet. Neurology|June 5, 2012
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trialCaroline Moreau, Arnaud Delval, Luc Defebvre, et al.
Brain : a Journal of Neurology|October 3, 2023
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's diseaseMatthieu Béreau, Astrid Kibleur, Mathieu Servant, et al.
Brain : a Journal of Neurology|March 26, 2015
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's diseaseCaroline Moreau, Sayah Meguig, Jean-Christophe Corvol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 5, 2024
Amantadine use in the French prospective NS-Park cohortMargherita Fabbri, Vanessa Rousseau, Jean-Christophe Corvol, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Parkinson'S Disease|June 27, 2025
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's diseaseMathilde Boussac, Florent Faggianelli, Estelle Harroch, et al.
Journal of Parkinson'S Disease|December 13, 2021
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II)Mathilde Boussac, Christophe Arbus, Helene Klinger, et al.
Clinical Parkinsonism & Related Disorders|February 20, 2026
Effects of deep brain stimulation on non motor fluctuations in Parkinson's disease (assessed with the NMF severity scale)Christian Matta, Camille Comet, Corentin Gaillard, et al.
BMJ Neurology Open|January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysisAymeric Lanore, Marion Houot, Aymeric Basset, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2020
Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective StudyMarie des Neiges Santin, Paul Voulleminot, Agathe Vrillon, et al.
The Lancet. Neurology|June 5, 2012
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trialCaroline Moreau, Arnaud Delval, Luc Defebvre, et al.
Brain : a Journal of Neurology|October 3, 2023
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's diseaseMatthieu Béreau, Astrid Kibleur, Mathieu Servant, et al.
Brain : a Journal of Neurology|March 26, 2015
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's diseaseCaroline Moreau, Sayah Meguig, Jean-Christophe Corvol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 5, 2024
Amantadine use in the French prospective NS-Park cohortMargherita Fabbri, Vanessa Rousseau, Jean-Christophe Corvol, et al.
Pageof 9